Initial data for AlloNK® from autoimmune program expected H1 2025Updated clinical data from Phase 1/2 trial exploring AlloNK + rituximab in NHL ...
Serina Therapeutics (SER) announced that Randall Moreadith, CDO, will present new data at the ACS Spring 2025 Meeting and Expo in San Diego, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback